Transcripts

Myriad Genetics (MYGN) earnings call transcripts

Earnings call transcripts for Myriad Genetics Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed the call around payer-driven reimbursement friction, a sharper cancer-care focus and efficiency measures, while acknowledging weaker prenatal trends and cutting guidance.

    Jul 30, 2026Cautious-0.30